On September 24, 2018 Sangamo Therapeutics, Inc. (Nasdaq: SGMO) reported that management will participate in the following healthcare investor and industry conferences in September and October (Press release, Sangamo Therapeutics, SEP 24, 2018, View Source [SID1234529552]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2018 Jefferies Gene Therapy Summit, New York, NY, September 27, 2018
Sangamo’s presentation is scheduled for 2:05 p.m. ET on Thursday.

Cantor Fitzgerald 2018 Global Healthcare Conference, New York, NY, October 1-3, 2018
Sangamo’s presentation is scheduled for 12:15 p.m. ET on Tuesday, October 2nd.

ARM Cell & Gene Meeting on the Mesa, La Jolla, CA, October 3-5, 2018
Sangamo’s presentation is scheduled for 3:15 p.m. PT on Wednesday, October 3rd. Earlier that day, Sandy Macrae, CEO of Sangamo, is also scheduled to participate in a panel discussion titled, "Spotlight: Commercializing Gene Therapies for Hemophilia" at 10:45 a.m. PT.

2018 Chardan Genetic Medicines Conference, New York, NY, October 9, 2018
Sangamo’s presentation is scheduled for 3:15 p.m. ET on Tuesday.

The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the events.